Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma

被引：4

作者：

Eriksson, Hanna ^{[1
,2
,3
,5
]}

Hansson, Johan ^{[1
,2
,5
]}

Krynitz, Britta ^{[3
]}

Masucci, Giuseppe ^{[1
,2
,5
]}

Girnita, Ada ^{[1
]}

Lapins, Jan ^{[4
]}

Huen, Auris O. ^{[6
]}

Tawbi, Hussein A. ^{[7
]}

Davies, Michael A. ^{[7
,8
]}

Tetzlaff, Michael T. ^{[9
,10
]}

Curry, Jonathan L. ^{[9
,10
]}

机构：

[1] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden

[2] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden

[3] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden

[4] Karolinska Univ Hosp, Dept Dermatol, Stockholm, Sweden

[5] Karolinska Univ Hosp, Skin Canc Ctr, Theme Canc, Stockholm, Sweden

[6] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA

[8] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA

[9] Univ Texas MD Anderson Canc Ctr, Dept Translat & Mol Pathol, Houston, TX 77030 USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

来源：

ACTA DERMATO-VENEREOLOGICA | 2020年 / 100卷

关键词：

IMMUNE CHECKPOINT BLOCKADE; DERMATOLOGICAL TOXICITIES; T-CELL; EXPRESSION;

D O I：

10.2340/00015555-3648

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1 / 3

页数：3

共 14 条

[1] Lesional Th17 cells and regulatory T cells in bullous pemphigoid [J].

Arakawa, Masataka ;

Dainichi, Teruki ;

Ishii, Norito ;

Hamada, Takahiro ;

Karashima, Tadashi ;

Nakama, Takekuni ;

Yasumoto, Shinichiro ;

Tsuruta, Daisuke ;

Hashimoto, Takashi .

EXPERIMENTAL DERMATOLOGY, 2011, 20 (12) :1022-1024

[2] Diagnosis and classification of autoimmune blistering diseases [J].

Baum, Sharon ;

Sakka, Nicole ;

Artsi, Ofir ;

Trau, Henri ;

Barzilai, Aviv .

AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) :482-489

[3] A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid [J].

Buschman, KE ;

Seraly, M ;

Thong, HY ;

Deng, JS ;

Draviam, RP ;

Abernethy, JL .

JOURNAL OF CUTANEOUS PATHOLOGY, 2002, 29 (05) :282-286

[4] Diverse types of dermatologic toxicities from immune checkpoint blockade therapy [J].

Curry, Jonathan L. ;

Tetzlaff, Michael T. ;

Nagarajan, Priyadharsini ;

Drucker, Carol ;

Diab, Adi ;

Hymes, Sharon R. ;

Duvic, Madeleine ;

Hwu, Wen-Jen ;

Wargo, Jennifer A. ;

Torres-Cabala, Carlos A. ;

Rapini, Ronald P. ;

Prieto, Victor G. .

JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (02) :158-176

[5] Histological Features Associated With Vemurafenib-Induced Skin Toxicities: Examination of 141 Cutaneous Lesions Biopsied During Therapy [J].

Curry, Jonathan L. ;

Tetzlaff, Michael T. ;

Nicholson, Kimberly ;

Duvic, Madeleine ;

Kim, Kevin B. ;

Tsai, Kenneth Y. ;

Hwu, Wen-Jen ;

Hong, David S. ;

Prieto, Victor G. ;

Torres-Cabala, Carlos A. .

AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2014, 36 (07) :557-561

[6] Management of Treatment-Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma [J].

Daud, Adil ;

Tsai, Katy .

ONCOLOGIST, 2017, 22 (07) :823-833

[7] Skin biopsy Biopsy issues in specific diseases [J].

Elston, Dirk M. ;

Stratman, Erik J. ;

Miller, Stanley J. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (01) :1-16

[8] BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma [J].

Frederick, Dennie T. ;

Piris, Adriano ;

Cogdill, Alexandria P. ;

Cooper, Zachary A. ;

Lezcano, Cecilia ;

Ferrone, Cristina R. ;

Mitra, Devarati ;

Boni, Andrea ;

Newton, Lindsay P. ;

Liu, Chengwen ;

Peng, Weiyi ;

Sullivan, Ryan J. ;

Lawrence, Donald P. ;

Hodi, F. Stephen ;

Overwijk, Willem W. ;

Lizee, Gregory ;

Murphy, George F. ;

Hwu, Patrick ;

Flaherty, Keith T. ;

Fisher, David E. ;

Wargo, Jennifer A. .

CLINICAL CANCER RESEARCH, 2013, 19 (05) :1225-1231

[9] Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions [J].

Jour, George ;

Glitza, Isabella C. ;

Ellis, Rachel M. ;

Torres-Cabala, Carlos A. ;

Tetzlaff, Michael T. ;

Li, Janet Y. ;

Nagarajan, Priyadharsini ;

Huen, Auris ;

Aung, Phyu P. ;

Ivan, Doina ;

Drucker, Carol R. ;

Prieto, Victor G. ;

Rapini, Ronald P. ;

Patel, Anisha ;

Curry, Jonathan L. .

JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (08) :688-696

[10] PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients [J].

Kakavand, Hojabr ;

Wilmott, James S. ;

Menzies, Alexander M. ;

Vilain, Ricardo ;

Haydu, Lauren E. ;

Yearley, Jennifer H. ;

Thompson, John F. ;

Kefford, Richard F. ;

Hersey, Peter ;

Long, Georgina V. ;

Scolyer, Richard A. .

CLINICAL CANCER RESEARCH, 2015, 21 (14) :3140-3148

← 1 2 →